Clinical Trial Update: Observational Registry Study of Quality of Life When Treating BTcP With Abstral

View source ↗

Summary

Observational registry study assessing quality of life in cancer patients treated for breakthrough cancer pain with Abstral has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Abstral (fentanyl)

Snippet

Sponsor: Galena Biopharma, Inc. | Conditions: Quality of Life, Breakthrough Cancer Pain | Status: COMPLETED